About Dr. Joe Galati

Dr. Joe Galati is a Liver Specialist practicing in Houston, Texas. His practice, Liver Specialists of Texas is dedicated to the care of patients with all facets of liver disease.
Archive by Author

Saving the American Family: Roasting Vegetables-Dr. Galati Shows How

I enjoy cooking. Thanks to my parents, and my Italian heritage, cooking has always been a big part of my life. Cooking requires teamwork. Cooking requires communication amongst participants. Cooking requires people working as a team. Cooking requires everyone be be in the “present”. Cooking is a great way to keep families together. As the family unit has disintegrated, I firmly believe that the time spent cooking as a family has also declined. As a result, more and more meals are eaten out, on the road, in your car, and alone.

The strategy to save the American family might simply lie in the kitchen. Imagine families gathering around preparing home-cooked meals? Imagine families sharing these meals together at the table? Imagine the conversations that will take place at the table? Parents listening to children, and children listening to parents.

I’ll write more on this. Send me your feedback. Enjoy the video.

Dr. Joe Galati
Houston, Texas

 

Comments { 0 }

Fight Obesity: Dr. Joe Galati’s Great American Produce Giveaway

I have been educating patients for a long time. It’s the best part of my job. Educate, educate, educate. Despite all of my efforts, there are frustrating days where I feel we are losing the war on obesity. The general population is lax on what they eat, and settle for junk. Everyone is too busy to cook a fresh meal at home. Children grow up eating highly processed foods, get fat, and develop diabetes, fatty liver disease, heart disease, and lots more. Why? People can’t pick out a cucumber from a zucchini, let along how to cook the darn thing.

The Great American Produce Giveaway is my answer to all this. Some may laugh (and I hope it puts a smile on your face), and some may just not get it. Yes, it is a naive way to stimulate conversation, but it’s a start. Share it with your friends and family, and buy a vegetable for your neighbor.

Dr. Joe Galati
Houston, Texas

Comments { 0 }

Take the Poll: Where Do You Get Your Health Information From?


Comments { 1 }

“I am Ready” for Hepatitis C Treatment: New Harvoni TV Commercial

This past week, Gilead Sciences, maker of the new hepatitis C therapies Harvoni and Sovaldi, launched their first TV commercial, promoting their latest hepatitis C cures.

For the past year, we have seen an explosion of new, highly effective therapies for hepatitis C, now with the ability to cure the virus. Yes, we can now say CURE. All of the companies involved in hepatitis C therapy have developed a wide range of print, radio, and television ads. The goal is to increase awareness, one of the major problems those of us that treat HCV find. There are more people yet to be diagnosed with hepatitis C, than those already diagnosed and treated. Getting the word out to get tested is still a struggle.

The messages thus far have varied in their content, including “Breaking the Silence” (Janssen-makers of Olysio/Simeprevir), “Take Action Now” (AbbVie-makers of Viekira Pak), and “Forget Me Not” (Gilead-makers of Sovaldi). Now, Gilead with their latest commercial, for the first time, directly states the name of their product, and outlines the near 99% cure rate one can expect, and the minimal side effects patients experience. The “I am Ready” campaign hopes to alert all those living with hepatitis C, it’s time to get treated. Putting aside the bad memories of interferon, and other complicated therapies, that were indeed toxic, these new era therapies are highly effective, with the most minimal side effects. Patients have told me that the very fear of the therapy, and the wicked side effects,  have prevented them from coming forward for treatment. This is a shame, and should not even be considered any further. Having treated several hundred patients thus far with Harvoni and the other current medicines, we are truly in a golden era where we can eradicate HCV, and prevent all of the know complications, such as cirrhosis and liver cancer.

Call us if you are ready to be treated.

Watch the vidoe below.

 

 

 

 

Comments { 1 }

What Autopsies Can Teach: Melinda Beck from the Wall Street Journal

Read the article here.

What Autopsies Can Teach: Melinda Beck and the Wall Street Journal by Your Health First Radio on Mixcloud

Comments { 1 }
Dr. Rashid Khan Joins the Liver Specialists of Texas Team

Dr. Rashid Khan Joins the Liver Specialists of Texas Team

Dr. Rashid Khan will be joining Dr. Galati and Liver Specialists of Texas.

Dr. Rashid Khan will be joining Dr. Galati and Liver Specialists of Texas.

Dr. Rashid Khan will be joining Liver Specialists of Texas in July 2015.

Originally from Karachi, Pakistan, he completed his medical school education at Dow Medical College, Karachi, the second oldest medical school in the country. Following medical school, Dr. Khan was an Intern and Resident in Internal Medicine at the University of Texas Health Science Center-Houston. He completed his Gastroenterology training at the University of Texas Medical Branch in Galveston, Texas, under the direction of Dr. Don Powell and Dr. Roger Soloway. Wanting to further his education in liver disease, he completed his training in Transplant Hepatology at the Baylor College of Medicine in Houston, under the direct mentorship of Dr. John Vierling.

During Dr. Khan’s training, he participated in a number of research studies related to liver disease and the complications of cirrhosis. Dr. Khan also has two years of prior experience of working as a Transplant Hepatologist at the Liver Transplant program at the University of Texas Medical Branch, Galveston.

When not practicing medicine, Dr. Khan enjoys spending time with his young family. His hobbies include travelling, and playing and watching basketball and soccer. He is excited about joining Dr. Galati and the Liver Specialists of Texas team. He shares in Dr. Galati’s vision in providing exceptional and compassionate patient care, and in providing the highest level of care to patients with all facets of liver disease and digestive disorders.

To make an appointment with Dr. Khan, call 713-794-0700.

Comments { 0 }

Low Salt Diet in Cirrhosis and Liver Disease: Advise to Patients and Family

In those patients with liver disease and cirrhosis, maintaining a diet low in salt (also knows as sodium) can be difficult at times. With all the eating out that America does, this processed food is overloaded with salt and sodium. Thus, it is nearly impossible to maintain a diet low in sodium. Usually, the target goal is to consume less than 2,000 mg per day.

A list of common foods and their sodium content is posted below. Remember to read labels, and determine the “serving size”.

Common Food Sodium Content

I have posted a new video on our YouTube page  giving you all some suggestions on maintaining this low salt diet. Send me your comments.

Dr. Joe Galati

Comments { 1 }

Grazoprevir and Elbasvir: New Hepatitis C Treatment Options with High Cure Rates

Wrapping up presentations at this years annual Liver Meetings in Boston, Dr. Eric Lawitz presented data on 2 new antiviral agents to treat chronic hepatitis C. This study looked at the more tough to treat populations.

These two drugs use in cirrhotic patients and those prior null responder to Peg-intron and ribavirin had between a 91-100% SVR.

The full article is posted in this weeks Lancet Journal.

Throughout the meeting, very encouraging data was presented about the very high cure rates we are seeing in hepatitis C. With no less than 6 new drugs being developed, in the months ahead, we will all see the slow evolution of these therapies, selecting specific drug combinations tailored to unique patient features, such as HCV genotype, prior response to therapy, presence or absence of cirrhosis, renal failure (with or without dialysis), HIV status, and whether the patient has had a liver transplant.

As with all of these therapies, cost will be factored into the course of treatment.

Comments { 0 }
Liver Transplant with Donors Over 80 Years Old Do Well

Liver Transplant with Donors Over 80 Years Old Do Well

A research paper presented this morning at the AASLD Liver Meeting indicates that liver donors 80 years of age and older do just as well as those receiving a liver transplant from a donor less than 80 years old.

Considering the large number of patients awaiting liver transplant, and the associated limited number of suitable donors, resulting in unacceptable wait-list deaths, serious consideration should be given to accepting older donors, especially those over 80 years old.

IMG_2140-1.PNG

Comments { 1 }

Olysio and Sovaldi Now Approved for Hepatitis C

As the treatments for chronic hepatitis C continue to expand, and provide a superior cure rate, the FDA has approved the combination of both Sovaldi(sofosbuvir) and Olysio (simeprevir) for treating HCV. We have been using this combination, but it was not officially approved, causing some insurance related issues for some patients.

Here is one of many press releases.

All this means is a superior cure rate, and help for those who suffer from chronic liver disease.

Call us for an appointment for treatment consideration.

 

Comments { 0 }